Sonoma Pharmaceuticals (SNOA) Raw Materials (2012 - 2025)

Sonoma Pharmaceuticals' Raw Materials history runs 13 years deep, the most recent figure standing at $2.1 million for Q4 2025.

• In Q4 2025, Raw Materials rose 50.29% year-over-year to $2.1 million; the TTM figure through Dec 2025 stood at $2.1 million (up 50.29% YoY), while the FY2025 annual figure was $1.4 million, down 22.59% from the prior year.
• Raw Materials was $2.1 million for Q4 2025 at Sonoma Pharmaceuticals, up from $2.0 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $2.1 million in Q4 2025 to a low of $1.4 million in Q4 2024.
• Historically, Raw Materials has averaged $1.7 million across 5 years, with a median of $1.6 million in 2021.
• The sharpest annual moves came in 2021 and 2025: Raw Materials slumped 40.81% in 2021, then jumped 50.29% in 2025.
• A 5-year view of Raw Materials shows it stood at $1.6 million in 2021, then dropped by 0.98% to $1.6 million in 2022, then slipped by 6.46% to $1.5 million in 2023, then declined by 8.69% to $1.4 million in 2024, then surged by 50.29% to $2.1 million in 2025.
• The last three Raw Materials figures came in at $2.1 million (Q4 2025), $2.0 million (Q3 2025), and $1.8 million (Q2 2025), per Business Quant data.